Pharmacological Approach to Improve the Outcome of Social Cognition Training

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Schizophrenia
Interventions
DRUG

Oxytocin

Oxytocin 40 IU, intranasal inhalation

OTHER

Placebo

Placebo, matched to Oxytocin, intranasal inhalation

BEHAVIORAL

Social Cognitive Skills Training

The training utilizes skill building techniques that are commonly used in psychiatric rehabilitation. These include breaking down complex social cognitive processes into their components and automating these skills through repetition and practice. The training programs will include 12 sessions and will be administered in a small group format (6-8 participants per group) twice a week for 6 weeks. Each training session will last for about 90 minutes (1 hour training and 30 minutes between drug administration and start of training).

Trial Locations (1)

90073

West Los Angeles VA Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Alliance for Research in Schizophrenia and Affective Disorders

UNKNOWN

lead

VA Greater Los Angeles Healthcare System

FED

NCT01517360 - Pharmacological Approach to Improve the Outcome of Social Cognition Training | Biotech Hunter | Biotech Hunter